Shagun Singh
Stock Analyst at RBC Capital
(3.45)
# 916
Out of 5,072 analysts
242
Total ratings
53.47%
Success rate
1.8%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Outperform | $370 → $380 | $326.80 | +16.28% | 4 | Nov 21, 2025 | |
| MDT Medtronic | Maintains: Outperform | $111 → $118 | $105.02 | +12.36% | 22 | Nov 19, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $22 → $17 | $4.44 | +282.88% | 14 | Nov 11, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $135 → $120 | $115.29 | +4.09% | 23 | Nov 7, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $88 → $92 | $91.08 | +1.01% | 6 | Nov 7, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $211 → $202 | $193.90 | +4.18% | 3 | Nov 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $111 → $101 | $97.55 | +3.54% | 17 | Nov 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $127.33 | -1.83% | 7 | Nov 4, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $89 → $95 | $86.75 | +9.51% | 23 | Oct 31, 2025 | |
| DXCM DexCom | Maintains: Outperform | $100 → $85 | $62.53 | +35.93% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $615 → $625 | $574.23 | +8.84% | 17 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $147 | $128.54 | +14.36% | 17 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $125 | $100.96 | +23.81% | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $20.73 | +20.60% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $330 → $325 | $295.96 | +9.81% | 15 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $185 | $207.56 | -10.87% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.59 | +88.68% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $372.29 | +16.84% | 19 | Jan 29, 2025 |
Insulet
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $326.80
Upside: +16.28%
Medtronic
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $105.02
Upside: +12.36%
Outset Medical
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $4.44
Upside: +282.88%
Teleflex
Nov 7, 2025
Maintains: Sector Perform
Price Target: $135 → $120
Current: $115.29
Upside: +4.09%
Globus Medical
Nov 7, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $91.08
Upside: +1.01%
Becton, Dickinson and Company
Nov 7, 2025
Maintains: Sector Perform
Price Target: $211 → $202
Current: $193.90
Upside: +4.18%
Zimmer Biomet Holdings
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $97.55
Upside: +3.54%
Inspire Medical Systems
Nov 4, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $127.33
Upside: -1.83%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $89 → $95
Current: $86.75
Upside: +9.51%
DexCom
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $62.53
Upside: +35.93%
Oct 22, 2025
Maintains: Outperform
Price Target: $615 → $625
Current: $574.23
Upside: +8.84%
Oct 16, 2025
Reiterates: Outperform
Price Target: $147
Current: $128.54
Upside: +14.36%
Sep 29, 2025
Reiterates: Outperform
Price Target: $125
Current: $100.96
Upside: +23.81%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $20.73
Upside: +20.60%
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $295.96
Upside: +9.81%
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $207.56
Upside: -10.87%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.59
Upside: +88.68%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $372.29
Upside: +16.84%